SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
EntreMed (ENMD)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
2135 59 0 ENMD
Emcee:  Mark Wise Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
35 Sid, Thalidimide is a potent angiogenesis inhibitor but only a hundreth as powGraham Dellaire-5/8/1997
34 Mark: In the end, it may well be that more than one company has products that aSid Turtlman-5/8/1997
33 There is another competitor in the anti-angiogenesis market that I have not seeMark Wise-5/8/1997
32 John I hope this occurs before there stock goes off the map is trading for halfGraham Dellaire-5/8/1997
31 Faukman had been doing this for 20 years and ENMD has one FDA approved compoundGraham Dellaire-5/8/1997
30 John: Although I do not dispute your estimates for the total market, they do sJohn Bloxom-5/8/1997
29 John: Why do you think that BLSI will win the race? Since both BLSI and ENMD aSid Turtlman-5/7/1997
28 Estimated market for a antiangiogenesis compound is 700 mil. to 1 bil. per yearjohn e vanden biesen-5/7/1997
27 This is frustrating. Why are the MM`s holding the price at 10 7/8 ? The volumGraham Dellaire-5/7/1997
26 I didn't mean adjusted; I meant unadjusted. I agree that speculating aboutJohn Bloxom-5/7/1997
25 John more than a hundred a share adjusted is nieve... come on! I think that inGraham Dellaire-5/6/1997
24 With all due respect, I think $100 p/s is low by a factor of 4x asuming, of couJohn Bloxom-5/6/1997
23 I always pay the ask. I figure the market makers have kids to send to college John Bloxom-5/6/1997
22 I have set a bid half way between the bid and ask twice and never had my order Graham Dellaire-5/5/1997
21 Graham: Why are you having problems getting into ENMD? Ciao, TedCage Rattler-5/5/1997
20 Graham: Well, if the company really does have a cure for cancer, then it will bSid Turtlman-5/5/1997
19 This is a bitch of stock to get into... Twice I have tried and no luck ImagineGraham Dellaire-5/5/1997
18 Yes they have synthesize it in yeast production but the article says, "Brijohn e vanden biesen-5/4/1997
17 John: I think, if I am reading this story correctly, that ENMD has synthesized Sid Turtlman-5/4/1997
16 BLSI has Therafectin,a nontoxic med. for rheumatoid arthritis and Altropane,thejohn e vanden biesen-5/3/1997
15 John: You say that ENMD has a six month lead on BLSI, but the latter is due to Sid Turtlman-5/3/1997
14 Reguarding antiangiogenesis foxman worked in cojunction with dr. langer at harvjohn e vanden biesen-5/2/1997
13 Graham: The whole biotech sector is in a slump at the moment. Part of it is tJohn Bloxom-4/24/1997
12 John Why the overall weakness right now... it is lagging other biotechs?? I amGraham Dellaire-4/23/1997
11 This one is a real swing for the fences. My broker tells me that at some pointJohn Bloxom-4/23/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News